EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keh, D.
Right arrow Articles by Falke, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keh, D.
Right arrow Articles by Falke, K. J.

European Journal of Cardio-Thoracic Surgery, Vol 9, 226-229, Copyright © 1995 by European Association for Cardio-thoracic Surgery


ARTICLES

Extracorporeal membrane oxygenation with heparin-coated systems in a 13- month-old infant with acute hypoxic respiratory failure after correction of tetralogy of Fallot

D Keh, R Rossaint, R Streich, H Gerlach, D Pappert, H Kramer and KJ Falke
Department of Anesthesiology and Intensive Care Medicine, Rudolf Virchow Clinic, Free University of Berlin, Germany.

Hemorrhagic disorders due to systemic heparinization are frequent during extracorporeal lung support (veno-venous extracorporeal membrane oxygenation: vv-ECMO). The development of heparin-coated systems has reduced the need for high-dose heparinization. Whereas the use of these heparin-coated membrane lungs and tubings has been described in former studies in adults, only few reports exist in children. This case report describes the application of a heparin-coated extracorporeal system for long-term vv-ECMO in a 13-month-old infant suffering from acute hypoxic respiratory failure after correction of tetralogy of Fallot. Only moderately elevated levels of activated clotting time (ACT, 120-160 s) and activated partial thromboplastin time (aPTT, 40-60 s) were necessary to avoid thrombotic events in the extracorporeal system. Thoracotomies were performed twice without bleeding complications by discontinuation of the systemic heparinization. We conclude that the use of heparin-coated membrane lungs in infants may improve the safety of extracorporeal lung support and permits surgical intervention without major risk of bleeding.


This article has been cited by other articles:


Home page
PerfusionHome page
A. H Stammers, L. W Fristoe, K. Christensen, J. Deptula, R T. Sydzyik, D. Zavadil, and L. Willett
Coagulopathic-induced membrane dysfunction during extracorporeal membrane oxygenation: a case report
Perfusion, March 1, 1997; 12(2): 143 - 149.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.